Global /South Korea /Healthcare /Medical Distribution /115450

HLB Therapeutics Co.,Ltd.

115450

• KRX: 115450 • Delayed

3,530KRW 1.3%

2.34 USD

As of 19 June 2026, HLB Therapeutics Co.,Ltd. has a market cap of $211.95M USD, ranking #20654 globally and #780 in South Korea. It ranks #1853 in the Healthcare sector, and #66 in the Medical Distribution industry.

Global Rank

20654

Country Rank

780

Sector Rank

1853

Industry Rank

Key Stats

Market Cap

$211.95MUSD

326.75B KRW

Enterprise Value

$228.51MUSD

344.91B KRW

Revenue (TTM)

$45.12MUSD

69.56B KRW

EBITDA (TTM)

$689.23KUSD

1.04B KRW

Net Income (TTM)

-$5.99MUSD

-9.23B KRW

EBITDA Margin

1.5%

Profit Margin

-13%

PS Ratio

4.7

PB Ratio

1.9

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Medical Distribution

CEO

Ki Hong Ahn open_in_new

Employees

Founded

2000

Website

hlbtherapeutics.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1.3%	0.4%	14%	7.9%	8.3%	22%	-52%	-17%	-39%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	115450 (주)지트리비앤티 ISIN: KR7115450009 Shares Out.: Shares Outstanding: 88.155M¹ Shares Float: 76.352M² TV: TradingView: KRX: 115450 SA: Stock Analysis: KRX: 115450 YF: Yahoo Finance: 115450.KS GF: Google Finance: KRX: 115450 BA: Barron's: 115450 MS: Morningstar: XKRX: 115450	3,530 KRW	TV: TradingView: KRX: 115450 SA: Stock Analysis: KRX: 115450 YF: Yahoo Finance: 115450.KS GF: Google Finance: KRX: 115450 BA: Barron's: 115450 MS: Morningstar: XKRX: 115450

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About HLB Therapeutics Co.,Ltd.

HLB Therapeutics Co.,Ltd., a biotech company, develops pharmaceutical products in South Korea and internationally. It is developing GBT-201 using Thymosin beta for the treatment of ophthalmic diseases, such as dry eye syndrome and neurotrophic keratopathy; and OKN-007 for the treatment of glioblastoma brain tumor. It is also involved in the wholesale of vaccines, as well as manufactures electrical and electronic components, such as motors, pumps, and transformers. The company was formerly known as G-treeBNT Co., Ltd. and changed its name to HLB Therapeutics Co.,Ltd. in December 2021. HLB Therapeutics Co.,Ltd. was founded in 2000 and is headquartered in Seongnam-si, South Korea.

Similar Companies

Industry: Medical Distribution (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Hanmi Science Co., Ltd. KRX: 008930	$1.67B 2.57T KRW 687%	21.8	South Korea
HLB Life Science Co., Ltd. KRX: 067630	$339.48M 523.33B KRW 60%	-	South Korea
Manyo Factory Co., Ltd. KRX: 439090	$178.54M 275.24B KRW -16%	30.1	South Korea
Ensol Biosciences, Inc. KRX: 140610	$117.03M 180.42B KRW -45%	-	South Korea
Aminologics Co.,Ltd. KRX: 074430	$82.27M 126.82B KRW -61%	36.1	South Korea
BIO-FD&C Co.,Ltd. KRX: 251120	$80.72M 124.44B KRW -62%	18.3	South Korea

Industry: Medical Distribution (Global)

Name	Market Cap (USD) diff.	PE	Country
McKesson Corp. NYSE: MCK	$100.76B 47K%	24.0	United States
Cencora, Inc. NYSE: COR	$60.58B 28K%	37.4	United States
Cardinal Health, Inc. NYSE: CAH	$47.73B 22K%	29.6	United States
Henry Schein, Inc. NASDAQ: HSIC	$8.47B 4K%	22.6	United States
Sinopharm Group Co. Ltd. SHEK: 1099	$7.48B 58.61B HKD 3K%	7.2	China
Galenica AG SIX: GALE	$5.27B 4.2B CHF 2K%	23.0	Switzerland

chevron_leftBack